Learn More
Gibco™ Human LIF Recombinant Protein
Beschreibung
Reconstitution: Centrifuge the vial briefly, before opening to bring the contents to the bottom. Reconstitute the lyophilized protein in sterile, distilled water or appropriate buffered solution containing 0.1% BSA to regain full activity. Apportion there constituted protein into working aliquots and store at -20°C. Make any further dilutions of the reconstituted protein in buffered solution containing a carrier protein, such as PBS with 0.1% BSA. Storage: Store the lyophilized protein at 2-8°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles.
Spezifikation
Spezifikation
| Zugriffsnummer | P15018 |
| Zur Verwendung mit (Anwendung) | Control, ELISA, Functional Assay, Immunohistochemistry, Western Blot |
| Zusammensetzung | protein with no preservative |
| Gen-ID (Entrez) | 3976 |
| Molekulargewicht | 21 kDa |
| Name | Human LIF |
| Reinigungsverfahren | Sequential Chromatography |
| Menge | 10 μg |
| Endotoxin-Konzentration | <0.1 ng/μg |
| Gen-Alias | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Mehr anzeigen |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.